Literature DB >> 35976535

Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.

Sebastian Parusel1,2, Min-Hee Yi1, Christine L Hunt3, Long-Jun Wu4,5,6.   

Abstract

Chronic pain relief remains an unmet medical need. Current research points to a substantial contribution of glia-neuron interaction in its pathogenesis. Particularly, microglia play a crucial role in the development of chronic pain. To better understand the microglial contribution to chronic pain, specific regional and temporal manipulations of microglia are necessary. Recently, two new approaches have emerged that meet these demands. Chemogenetic tools allow the expression of designer receptors exclusively activated by designer drugs (DREADDs) specifically in microglia. Similarly, optogenetic tools allow for microglial manipulation via the activation of artificially expressed, light-sensitive proteins. Chemo- and optogenetic manipulations of microglia in vivo are powerful in interrogating microglial function in chronic pain. This review summarizes these emerging tools in studying the role of microglia in chronic pain and highlights their potential applications in microglia-related neurological disorders.
© 2022. The Author(s).

Entities:  

Keywords:  Chemogenetics; Chronic pain; DREADDs; Microglia; Optogenetics; ReaChR

Year:  2022        PMID: 35976535     DOI: 10.1007/s12264-022-00937-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.271


  122 in total

1.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

Review 2.  The neuropathic pain triad: neurons, immune cells and glia.

Authors:  Joachim Scholz; Clifford J Woolf
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

3.  Structural plasticity and reorganisation in chronic pain.

Authors:  Rohini Kuner; Herta Flor
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

Review 4.  Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential.

Authors:  Kazuhide Inoue; Makoto Tsuda
Journal:  Nat Rev Neurosci       Date:  2018-02-08       Impact factor: 34.870

5.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation.

Authors:  Annemarie Ledeboer; Evan M Sloane; Erin D Milligan; Matthew G Frank; John H Mahony; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

Review 6.  Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia.

Authors:  Makoto Tsuda; Kazuhide Inoue; Michael W Salter
Journal:  Trends Neurosci       Date:  2005-02       Impact factor: 13.837

Review 7.  Neuropathic pain.

Authors:  Luana Colloca; Taylor Ludman; Didier Bouhassira; Ralf Baron; Anthony H Dickenson; David Yarnitsky; Roy Freeman; Andrea Truini; Nadine Attal; Nanna B Finnerup; Christopher Eccleston; Eija Kalso; David L Bennett; Robert H Dworkin; Srinivasa N Raja
Journal:  Nat Rev Dis Primers       Date:  2017-02-16       Impact factor: 52.329

8.  Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy.

Authors:  Vasudeva Raghavendra; Flobert Tanga; Joyce A DeLeo
Journal:  J Pharmacol Exp Ther       Date:  2003-05-06       Impact factor: 4.030

Review 9.  Neuronal and microglial mechanisms of neuropathic pain.

Authors:  Min Zhuo; Gongxiong Wu; Long-Jun Wu
Journal:  Mol Brain       Date:  2011-07-30       Impact factor: 4.041

10.  Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury.

Authors:  Jiyun Peng; Nan Gu; Lijun Zhou; Ukpong B Eyo; Madhuvika Murugan; Wen-Biao Gan; Long-Jun Wu
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.